Madrigal Buys New Drugs To Fight Liver Disease

Madrigal Pharmaceuticals keeps busy. The company recently bought new drugs. They want these drugs to work with their main medicine, Rezdiffra. Rezdiffra treats a serious liver disease called MASH.

Doctors call this disease metabolic dysfunction-associated steatohepatitis, or MASH. It causes fat in the liver. This fat can lead to serious problems. Rezdiffra helps many patients.

Madrigal's CEO, Bill Sibold, shared his plan. He wants to help more patients with MASH. Adding new drugs can offer better treatment options. This shows Madrigal's commitment to fighting liver disease.

The company believes these new drugs can make a big difference. They could improve how well Rezdiffra works. This helps patients get healthier. Madrigal aims to give people better lives.

Source: FierceBiotech